MRNA Articles, Moderna Inc. - From 12/07/23

The S&P 500 Index has risen by 19% year-to-date, with three weeks remaining in the year and just a five percentage point gap from the all-time ...

Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 21.8% on an annualized basis producing an average annual return of 33.32...

Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer Inc (NYSE: PFE), alleging the pharmaceutical giant misrepr...

Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 22.22% on an annualized basis producing an average annual return of 33.3...

Moderna Inc (NASDAQ: MRNA) shares slipped on Tuesday trading after the European Patent Office said a contested mRNA patent owned by Moderna is...

BioNTech SE (NASDAQ: BNTX) has reported Q3 revenues of €895.3 million ($974.49 million), sharply down from €3.461 billion a year ago...

Moderna Inc (NASDAQ: MRNA) posted a loss for the third quarter on Thursday. Moderna reported a quarterly loss of $(9.53), down from EPS income of ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its holdings, with a significant sale of DraftKings Inc (NASDAQ:DKNG) shares an...

Risk appetite is surging again Thursday on Wall Street, with investors welcoming the Federal Reserve’s decision to keep rates unchanged and F...